These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18307882)

  • 1. [Establishment of animal model of breast cancer dormancy].
    Su GY; Liu YQ; Ren LR; Liu XF; Gu B; Dong JH; Gao J
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):760-3. PubMed ID: 18307882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell dormancy: implications for the biology and treatment of breast cancer.
    Fehm T; Mueller V; Marches R; Klein G; Gueckel B; Neubauer H; Solomayer E; Becker S
    APMIS; 2008; 116(7-8):742-53. PubMed ID: 18834416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy.
    Naumov GN; MacDonald IC; Weinmeister PM; Kerkvliet N; Nadkarni KV; Wilson SM; Morris VL; Groom AC; Chambers AF
    Cancer Res; 2002 Apr; 62(7):2162-8. PubMed ID: 11929839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases.
    Naumov GN; Townson JL; MacDonald IC; Wilson SM; Bramwell VH; Groom AC; Chambers AF
    Breast Cancer Res Treat; 2003 Dec; 82(3):199-206. PubMed ID: 14703067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated Tumor Cells and Dormancy in Breast Cancer Progression.
    Banys-Paluchowski M; Reinhardt F; Fehm T
    Adv Exp Med Biol; 2020; 1220():35-43. PubMed ID: 32304078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms governing metastatic dormancy in breast cancer.
    Dittmer J
    Semin Cancer Biol; 2017 Jun; 44():72-82. PubMed ID: 28344165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel model of dormancy for bone metastatic breast cancer cells.
    Marlow R; Honeth G; Lombardi S; Cariati M; Hessey S; Pipili A; Mariotti V; Buchupalli B; Foster K; Bonnet D; Grigoriadis A; Rameshwar P; Purushotham A; Tutt A; Dontu G
    Cancer Res; 2013 Dec; 73(23):6886-99. PubMed ID: 24145351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting Mouse Models to Recapitulate Clinical Tumor Dormancy and Recurrence in Breast Cancer.
    Gu Y; Bui T; Muller WJ
    Endocrinology; 2022 Jun; 163(6):. PubMed ID: 35560214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of B-cell lymphoma growth in syngeneic SJL/J mice. establishment of tumor dormancy following administration of anti-CD4 monoclonal antibody into tumor-bearing mice.
    Ohnishi K; Bonavida B
    Leukemia; 1993 Nov; 7(11):1801-6. PubMed ID: 8231249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Dormancy in Bone.
    Clements ME; Johnson RW
    Curr Osteoporos Rep; 2019 Oct; 17(5):353-361. PubMed ID: 31468498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis.
    Almog N; Henke V; Flores L; Hlatky L; Kung AL; Wright RD; Berger R; Hutchinson L; Naumov GN; Bender E; Akslen LA; Achilles EG; Folkman J
    FASEB J; 2006 May; 20(7):947-9. PubMed ID: 16638967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrins in breast cancer dormancy.
    Pontier SM; Muller WJ
    APMIS; 2008; 116(7-8):677-84. PubMed ID: 18834411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein.
    Goodison S; Kawai K; Hihara J; Jiang P; Yang M; Urquidi V; Hoffman RM; Tarin D
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3808-14. PubMed ID: 14506175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes and regulatory pathways involved in persistence of dormant micro-tumors.
    Almog N
    Adv Exp Med Biol; 2013; 734():3-17. PubMed ID: 23143972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor dormancy and the effect of selected drugs on the tumor-dormant state.
    Sato NL; Fujisawa N; Kato A; Maeda Y; Yamamoto Y
    Lab Anim Sci; 1992 Dec; 42(6):555-60. PubMed ID: 1479806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy.
    Spiliotaki M; Mavroudis D; Kapranou K; Markomanolaki H; Kallergi G; Koinis F; Kalbakis K; Georgoulias V; Agelaki S
    Breast Cancer Res; 2014 Nov; 16(6):485. PubMed ID: 25432416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro system to study tumor dormancy and the switch to metastatic growth.
    Barkan D; Green JE
    J Vis Exp; 2011 Aug; (54):. PubMed ID: 21860375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative insight into metastatic relapse of breast cancer.
    Hanin L; Pavlova L
    J Theor Biol; 2016 Apr; 394():172-181. PubMed ID: 26801873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression predicts dormant metastatic breast cancer cell phenotype.
    Ren Q; Khoo WH; Corr AP; Phan TG; Croucher PI; Stewart SA
    Breast Cancer Res; 2022 Jan; 24(1):10. PubMed ID: 35093137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.